Extended use of real‐time continuous glucose monitoring in adults with insulin‐requiring type 2 diabetes: Results from the first 26 weeks of the <scp>2GO</scp>‐<scp>CGM</scp> trial
Use of rtCGM demonstrates safe and sustained glycaemic improvement in rtCGM use with insulin-requiring type 2 diabetes during the first 26 weeks of the 2GO-CGM study.
Authors
- Jonathan Williman (ORCID: https://orcid.org/0000-0001-5080-4435)
- Ryan Paul (ORCID: https://orcid.org/0000-0002-1579-3870)
- Claire S. Lever (ORCID: https://orcid.org/0000-0002-0003-5591)
- Antony Watson
- Celeste Keesing (ORCID: https://orcid.org/0009-0006-5422-7659)
- Alisa Boucsein (ORCID: https://orcid.org/0000-0002-6266-8802)
- Benjamin John Wheeler (ORCID: https://orcid.org/0000-0003-3348-5238)
- Oscar T. Sergel‐Stringer (ORCID: https://orcid.org/0000-0003-4431-5533)
- Martin de Bock (ORCID: https://orcid.org/0000-0002-6998-7566)
- Rachael S. Sampson
Institutions
- Southern District Health Board (NZ)
- Waikato District Health Board (NZ)
- University of Waikato (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1111/dme.70025
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Dexcom